4 months ago
PRAX
AnalystsRudy LiRudy Li's Stock Forecasts
AnalystsRudy Li
Sectors:
Industries:
Analyst Ranking
Top 4%
#187 out of 5186 analysts
Average Return
+99.43%
Win Rate
79%23 out of 29
Risk vs Reward
Poor
Good
Rudy Li's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +711.53% | $38.09 | $309.11 | 2025-05-07 - 2026-02-02 | Strong Buy |
Praxis Precision Medicines IncPRAX | +452.38% | $55.96 | $309.11 | 2025-07-29 - 2026-02-02 | Strong Buy |
Alto Neuroscience IncANRO | +294.26% | $4.01 | $15.81 | 2025-09-29 - 2026-02-02 | Strong Buy |
Stoke Therapeutics IncSTOK | +272.52% | $8.26 | $30.77 | 2025-03-19 - 2026-02-02 | Strong Buy |
Stoke Therapeutics IncSTOK | +230.86% | $9.30 | $30.77 | 2025-02-19 - 2026-02-02 | Strong Buy |
Rudy Li Analyst Color
Get additional color on Rudy Li's coverage of popular stocks
Rudy Li's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Centessa Pharmaceuticals PLCCNTA | 4 | Strong Buy | $30.00 | +19.09% | Maintains | a month ago |
Bright Minds Biosciences IncDRUG | 3 | Strong Buy | $80.00 | N/A | Maintains | a month ago |
Praxis Precision Medicines IncPRAX | 3 | Strong Buy | $330.00 | +6.76% | Maintains | 4 months ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $55.00 | +32.69% | Maintains | 4 months ago |
Immunic IncIMUX | 1 | Strong Buy | $3.00 | +358.72% | Initiates Coverage On | 4 months ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $15.00 | -5.12% | Initiates Coverage On | 4 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $2.00 | +582.59% | Initiates Coverage On | 4 months ago |
Prothena Corp Public Ltd CoPRTA | 7 | Strong Buy | $18.00 | +102.02% | Maintains | 5 months ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $24.00 | -22.00% | Maintains | 6 months ago |
Definium Therapeutics IncDFTX | 4 | Strong Buy | $20.00 | +9.71% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.